Posts in category

Business


Terry White Group Limited today announced consolidated earnings before interest, tax, depreciation and amortisation of $3.59 million. Terry White Chemists retail sales are up 18% on a like-for-like basis, says …

EBOS has reported strong earnings growth for the six month to 31 December 2015, with total revenues hitting $3.4 billion. This represents growth of 8.3%, or 9% growth constant FX. …

The combined weight of Chemplus and the Terry White Group has seen the South Australian-based network reporting increased retail sales and the addition of two new pharmacies. The Terry White …

Terry White Group has announced the network’s first half (to 31 December 2015) retail sales had increased 18%, outperforming the industry average growth rate significantly. Terry White Group CEO Anthony …

EBOS Group Limited has entered into an agreement to acquire a leading New Zealand natural health products business, Red Seal, for NZ$80 million substantially bolstering the Group’s existing position in …

How to use social media such as Facebook, websites and twitter effectively in pharmacy and ensure all staff understand your social media policy.

Terry White Group has announced the appointment of Jane McKellar to its Board as an Independent Non-Executive Director. McKellar has more than 30 years’ international experience in senior management roles …

Vitaco Health Group—the company behind nutritional products including Aussie Bodies, Nutra-Life, Healtheries and Musashi—today made its debut on the ASX, positioning the company for the next phase of its growth. …

Terry White Group Limited, the parent of pharmacy franchisors Terry White Management and Chemplus, has announced Net Profit After Tax of $1.2 million, on the back of a 16% increase …

On the eve of the Vitafoods Asia expo in Hong Kong, one of the premier events for the global complementary medicines industry, Complementary Medicines Australia has welcomed the latest AusTrade …

The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest …

Slade Pharmacy Services has entered into agreements with Fresenius Kabi to purchase its Oncology Compounding Business in Australia. This includes all the TGA-licenced compounding facilities in Queensland, NSW and Victoria. …